These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 6818331)
1. Further studies on the erythrocyte uptake of lead in vitro in amyotrophic lateral sclerosis (ALS) patients and controls. Abnormal erythrocyte fragility in ALS. Ronnevi LO; Conradi S; Nise G J Neurol Sci; 1982; 57(1):143-56. PubMed ID: 6818331 [TBL] [Abstract][Full Text] [Related]
2. Increased fragility of erythrocytes from amyotrophic lateral sclerosis (ALS) patients provoked by mechanical stress. Ronnevi LO; Conradi S Acta Neurol Scand; 1984 Jan; 69(1):20-6. PubMed ID: 6702416 [TBL] [Abstract][Full Text] [Related]
3. Serum protein binding of lead in vitro in amyotrophic lateral sclerosis patients and controls. Conradi S; Ronnevi LO; Stibler H J Neurol Sci; 1978 Jun; 37(1-2):95-105. PubMed ID: 690666 [TBL] [Abstract][Full Text] [Related]
4. Nature and properties of cytotoxic plasma activity in amyotrophic lateral sclerosis. Ronnevi LO; Conradi S; Karlsson E; Sindhupak R Muscle Nerve; 1987 Oct; 10(8):734-43. PubMed ID: 3683447 [TBL] [Abstract][Full Text] [Related]
5. Identification of erythrocyte biomarkers in amyotrophic lateral sclerosis. Lima C; Pinto S; Napoleão P; Pronto-Laborinho AC; Barros MA; Freitas T; de Carvalho M; Saldanha C Clin Hemorheol Microcirc; 2016 Oct; 63(4):423-437. PubMed ID: 27258202 [TBL] [Abstract][Full Text] [Related]
6. Accumulation of altered aspartyl residues in erythrocyte membrane proteins from patients with sporadic amyotrophic lateral sclerosis. D'Angelo S; Trojsi F; Salvatore A; Daniele L; Raimo M; Galletti P; Monsurrò MR Neurochem Int; 2013 Nov; 63(6):626-34. PubMed ID: 24044898 [TBL] [Abstract][Full Text] [Related]
7. [Plasma and erythrocyte lipids in amyotrophic lateral sclerosis]. Maciejek Z; Jazdzewski B; Nicpoń K; Ochmański S Neurol Neurochir Pol; 1988; 22(5):387-93. PubMed ID: 3249611 [TBL] [Abstract][Full Text] [Related]
8. Erythrocytes' surface properties and stiffness predict survival and functional decline in ALS patients. Lopes CS; Pronto-Laborinho AC; Conceição VA; Freitas T; Matias GL; Gromicho M; Santos NC; de Carvalho M; Carvalho FA Biofactors; 2024; 50(3):558-571. PubMed ID: 38149762 [TBL] [Abstract][Full Text] [Related]
9. Metal concentrations in cerebrospinal fluid, blood, serum, plasma, hair, and nails in amyotrophic lateral sclerosis: A systematic review and meta-analysis. Kamalian A; Foroughmand I; Koski L; Darvish M; Saghazadeh A; Kamalian A; Razavi SZE; Abdi S; Dehgolan SR; Fotouhi A; Roos PM J Trace Elem Med Biol; 2023 Jul; 78():127165. PubMed ID: 37018859 [TBL] [Abstract][Full Text] [Related]
10. Increased plasma levels of lead in patients with amyotrophic lateral sclerosis compared with control subjects as determined by flameless atomic absorption spectrophotometry. Conradi S; Ronnevi LO; Vesterberg O J Neurol Neurosurg Psychiatry; 1978 May; 41(5):389-93. PubMed ID: 77896 [TBL] [Abstract][Full Text] [Related]
11. Cytotoxic activity in the plasma of amyotrophic lateral sclerosis (ALS) patients against normal erythrocytes. Quantitative determinations. Conradi S; Ronnevi LO J Neurol Sci; 1985 May; 68(2-3):135-45. PubMed ID: 4009202 [TBL] [Abstract][Full Text] [Related]
15. Blood lead, manganese, and aluminum levels in a regional Italian cohort of ALS patients: does aluminum have an influence? Garzillo EM; Lamberti M; Genovese G; Pedata P; Feola D; Sannolo N; Daniele L; Trojsi F; Monsurro MR; Miraglia N J Occup Environ Med; 2014 Oct; 56(10):1062-6. PubMed ID: 25285828 [TBL] [Abstract][Full Text] [Related]
16. Methionine adenosyltransferase activity in erythrocytes and spinal cord of patients with sporadic amyotrophic lateral sclerosis. Ekegren T; Askmark H; Aquilonius SM; Gomes-Trolin C Exp Neurol; 1999 Aug; 158(2):422-7. PubMed ID: 10415148 [TBL] [Abstract][Full Text] [Related]
17. Blood Metal Levels and Amyotrophic Lateral Sclerosis Risk: A Prospective Cohort. Peters S; Broberg K; Gallo V; Levi M; Kippler M; Vineis P; Veldink J; van den Berg L; Middleton L; Travis RC; Bergmann MM; Palli D; Grioni S; Tumino R; Elbaz A; Vlaar T; Mancini F; Kühn T; Katzke V; Agudo A; Goñi F; Gómez JH; Rodríguez-Barranco M; Merino S; Barricarte A; Trichopoulou A; Jenab M; Weiderpass E; Vermeulen R Ann Neurol; 2021 Jan; 89(1):125-133. PubMed ID: 33068316 [TBL] [Abstract][Full Text] [Related]
18. Immunoglobulin-mediated activity against red blood cells in the saliva of amyotrophic lateral sclerosis (ALS) patients. Conradi S; Ronnevi LO; Karlsson E; Sindhupak R Acta Neurol Scand; 1990 Feb; 81(2):103-7. PubMed ID: 2327228 [TBL] [Abstract][Full Text] [Related]
19. Lead in cerebrospinal fluid and its relationship to plasma lead in humans. Cavalleri A; Minoia C; Ceroni M; Poloni M J Appl Toxicol; 1984 Apr; 4(2):63-5. PubMed ID: 6736552 [TBL] [Abstract][Full Text] [Related]
20. Effect of lead in vitro on water metabolism and osmotic fragility of human erythrocytes. Karai I; Fukumoto K; Kageyama K; Horiguchi S Br J Ind Med; 1982 Aug; 39(3):295-9. PubMed ID: 7093158 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]